Quality of Life of Ghanaian Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitors

被引:0
作者
Kuma, A. Benneh-Akwasi [1 ,2 ]
Amponsah, E. [3 ]
Kyeremeh, R. [3 ]
Olayemi, E. [1 ,2 ]
机构
[1] Univ Ghana, Haematol, Accra, Ghana
[2] Korle Bu Teaching Hosp, Accra, Ghana
[3] Univ Ghana, Med Lab Sci, Accra, Ghana
关键词
Chronic myeloid leukaemia; Ghana; Quality of Life; Tyrosine Kinase Inhibitor;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BSH18-PO-0
引用
收藏
页码:67 / 68
页数:2
相关论文
共 50 条
  • [31] Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Sasaki, Koji
    Kantarjian, Hagop M.
    O'Brien, Susan
    Ravandi, Farhad
    Konopleva, Marina
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Wierda, William G.
    Daver, Naval
    Ferrajoli, Alessandra
    Takahashi, Koichi
    Jain, Preetesh
    Rios, Mary Beth
    Pierce, Sherry A.
    Jabbour, Elias J.
    Cortes, Jorge E.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (05) : 545 - 552
  • [32] Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factors
    Ross, David M.
    Arthur, Chris
    Burbury, Kate
    Ko, Brian S.
    Mills, Anthony K.
    Shortt, Jake
    Kostner, Karam
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 5 - 13
  • [33] Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
    Koji Sasaki
    Hagop M. Kantarjian
    Susan O’Brien
    Farhad Ravandi
    Marina Konopleva
    Gautam Borthakur
    Guillermo Garcia-Manero
    William G. Wierda
    Naval Daver
    Alessandra Ferrajoli
    Koichi Takahashi
    Preetesh Jain
    Mary Beth Rios
    Sherry A. Pierce
    Elias J. Jabbour
    Jorge E. Cortes
    International Journal of Hematology, 2019, 109 : 545 - 552
  • [34] Dynamic change of T315I BCR-ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors
    Kim, Wan-Seok
    Kim, Dongho
    Kim, Dong-Wook
    Kweon, Il-Young
    Kim, Soo-Hyun
    Goh, Hyun-Gyung
    Park, Sa-Hee
    Lee, Jeong
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (02) : 82 - 88
  • [35] Stochastic modelling of tyrosine kinase inhibitor rotation therapy in chronic myeloid leukaemia
    H. Jonathan G. Lindström
    Astrid S. de Wijn
    Ran Friedman
    BMC Cancer, 19
  • [36] Health-Related Quality of Life in Patients with Chronic Myeloid Leukemia Treated with First- Versus Second-Generation Tyrosine Kinase Inhibitors
    Shacham Abulafia, Adi
    Shemesh, Sivan
    Rosenmann, Lena
    Berger, Tamar
    Leader, Avi
    Sharf, Giora
    Raanani, Pia
    Rozovski, Uri
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 9
  • [37] Outcomes of 219 chronic myeloid leukaemia patients with additional chromosomal abnormalities and/or tyrosine kinase domain mutations
    Xue, Mingming
    Cheng, Juan
    Zhao, Jiangyun
    Zhang, Shuling
    Jian, Jinli
    Qiao, Yanhong
    Liu, Bei
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (01) : 94 - 101
  • [38] Stochastic modelling of tyrosine kinase inhibitor rotation therapy in chronic myeloid leukaemia
    Lindstrom, H. Jonathan G.
    de Wijn, Astrid S.
    Friedman, Ran
    BMC CANCER, 2019, 19 (1)
  • [39] Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study
    Cécile Conte
    Flora Vayr
    Marie-Christelle Pajiep
    Fabien Despas
    Françoise Huguet
    Maryse Lapeyre Mestre
    Martin Gauthier
    Fabrice Herin
    Supportive Care in Cancer, 2022, 30 : 5431 - 5440
  • [40] Impact of the treatment of chronic myeloid leukaemia by tyrosine-kinase inhibitors on sick leaves refund: a nationwide cohort study
    Conte, Cecile
    Vayr, Flora
    Pajiep, Marie-Christelle
    Despas, Fabien
    Huguet, Francoise
    Mestre, Maryse Lapeyre
    Gauthier, Martin
    Herin, Fabrice
    SUPPORTIVE CARE IN CANCER, 2022, 30 (06) : 5431 - 5440